BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 32078236)

  • 1. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.
    Wu X; Shen J; Xiao Z; Li J; Zhao Y; Zhao Q; Cho CH; Li M
    Biochem Pharmacol; 2019 May; 163():425-439. PubMed ID: 30857828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs in gastric cancer.
    Ishiguro H; Kimura M; Takeyama H
    World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
    Li BS; Zuo QF; Zhao YL; Xiao B; Zhuang Y; Mao XH; Wu C; Yang SM; Zeng H; Zou QM; Guo G
    Oncogene; 2015 May; 34(20):2556-65. PubMed ID: 25043310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.
    Ishimoto T; Baba H; Izumi D; Sugihara H; Kurashige J; Iwatsuki M; Tan P
    Int J Cancer; 2016 Mar; 138(6):1337-49. PubMed ID: 26041092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA PLEC acts as a sponge of microRNA-198 to promote gastric carcinoma cell resistance to paclitaxel and tumorigenesis.
    Zhou N; Wang W; Xu C; Yu W
    Pathol Res Pract; 2021 Aug; 224():153487. PubMed ID: 34225215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Expression of Several Circular RNAs and Knockdown of hsa_circ_0005556 Exerts Oncogenic Functions by miR-767-5p in Gastric Cancer.
    Geng H; Li K; Pan Q; Tao S; Li C; Zhao H; Zhao X
    Med Sci Monit; 2020 Jul; 26():e921163. PubMed ID: 32728015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
    Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
    Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
    Hu M; Zhu S; Xiong S; Xue X; Zhou X
    Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR-124-3p / DNMT3B axis.
    Li Y; Yan J; Wang Y; Wang C; Zhang C; Li G
    Cell Biochem Funct; 2020 Dec; 38(8):1079-1088. PubMed ID: 32526811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.
    Han TS; Hur K; Xu G; Choi B; Okugawa Y; Toiyama Y; Oshima H; Oshima M; Lee HJ; Kim VN; Chang AN; Goel A; Yang HK
    Gut; 2015 Feb; 64(2):203-14. PubMed ID: 24870620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.
    Huang T; Zhou Y; Zhang J; Wong CC; Li W; Kwan JSH; Yang R; Chan AKY; Dong Y; Wu F; Zhang B; Cheung AHK; Wu WKK; Cheng ASL; Yu J; Wong N; Kang W; To KF
    Oncogene; 2018 Mar; 37(9):1159-1174. PubMed ID: 29234151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M; Qin S; Cao F; Ding S; Li M
    Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives on the dysregulated microRNAs in gastric cancer.
    Azarbarzin S; Safaralizadeh R; Khojasteh MB; Baghbanzadeh A; Baradaran B
    Mol Biol Rep; 2020 Sep; 47(9):7253-7264. PubMed ID: 32776162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.